Cardlytics Statistics
Total Valuation
Cardlytics has a market cap or net worth of $545.63 million. The enterprise value is $719.89 million.
| Market Cap | 545.63M |
| Enterprise Value | 719.89M |
Important Dates
The next estimated earnings date is Thursday, May 2, 2024, after market close.
| Earnings Date | May 2, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Cardlytics has 44.11 million shares outstanding. The number of shares has increased by 9.18% in one year.
| Shares Outstanding | 44.11M |
| Shares Change (YoY) | +9.18% |
| Shares Change (QoQ) | +3.85% |
| Owned by Insiders (%) | 3.37% |
| Owned by Institutions (%) | 63.79% |
| Float | 37.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 191.50 |
| PS Ratio | 1.76 |
| Forward PS | 1.58 |
| PB Ratio | 4.05 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.33 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.31, with a Debt / Equity ratio of 1.97.
| Current Ratio | 1.31 |
| Quick Ratio | 1.27 |
| Debt / Equity | 1.97 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -56.66 |
Financial Efficiency
Return on equity (ROE) is -65.00% and return on invested capital (ROIC) is -31.90%.
| Return on Equity (ROE) | -65.00% |
| Return on Assets (ROA) | -21.30% |
| Return on Capital (ROIC) | -31.90% |
| Revenue Per Employee | $712,452 |
| Profits Per Employee | -$310,373 |
| Employee Count | 434 |
| Asset Turnover | 0.49 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +104.13% in the last 52 weeks. The beta is 1.47, so Cardlytics's price volatility has been higher than the market average.
| Beta (1Y) | 1.47 |
| 52-Week Price Change | +104.13% |
| 50-Day Moving Average | 10.93 |
| 200-Day Moving Average | 10.87 |
| Relative Strength Index (RSI) | 48.80 |
| Average Volume (30 Days) | 1,802,933 |
Short Selling Information
The latest short interest is 5.95 million, so 13.49% of the outstanding shares have been sold short.
| Short Interest | 5.95M |
| Short Previous Month | 4.48M |
| Short % of Shares Out | 13.49% |
| Short % of Float | 15.81% |
| Short Ratio (days to cover) | 1.88 |
Income Statement
In the last 12 months, Cardlytics had revenue of $309.20 million and -$134.70 million in losses. Loss per share was -$3.69.
| Revenue | 309.20M |
| Gross Profit | 130.38M |
| Operating Income | -127.87M |
| Pretax Income | -134.70M |
| Net Income | -134.70M |
| EBITDA | -102.85M |
| EBIT | -132.37M |
| Loss Per Share | -$3.69 |
Balance Sheet
The company has $91.83 million in cash and $266.10 million in debt, giving a net cash position of -$174.27 million or -$3.95 per share.
| Cash & Cash Equivalents | 91.83M |
| Total Debt | 266.10M |
| Net Cash | -174.27M |
| Net Cash Per Share | -$3.95 |
| Equity / Book Value | 134.80M |
| Book Value Per Share | 3.06 |
| Working Capital | 52.78M |
Cash Flow
In the last 12 months, operating cash flow was -$185,000 and capital expenditures -$12.39 million, giving a free cash flow of -$12.58 million.
| Operating Cash Flow | -185,000 |
| Capital Expenditures | -12.39M |
| Free Cash Flow | -12.58M |
| FCF Per Share | -$0.35 |
Margins
Gross margin is 42.17%, with operating and profit margins of -41.36% and -43.56%.
| Gross Margin | 42.17% |
| Operating Margin | -41.36% |
| Pretax Margin | -43.56% |
| Profit Margin | -43.56% |
| EBITDA Margin | -33.26% |
| EBIT Margin | -42.81% |
| FCF Margin | -4.07% |
Dividends & Yields
Cardlytics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.18% |
| Shareholder Yield | -9.18% |
| Earnings Yield | -24.69% |
| FCF Yield | -2.31% |
Analyst Forecast
The average price target for Cardlytics is $15.50, which is 25.30% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.50 |
| Price Target Difference | 25.30% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Cardlytics has an Altman Z-Score of -2.08 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.08 |
| Piotroski F-Score | 4 |